Analysts have raised their price target for Nasdaq, increasing it by approximately $0.78 to $103.13. They cite accelerating revenue growth across its solutions business and a constructive outlook supported by recent research updates.
Analyst Commentary
Recent Street research on Nasdaq reflects a largely positive outlook, with several analysts upgrading ratings and raising price targets in response to the company's earnings performance, revenue momentum, and ongoing transformation efforts. However, some areas of caution remain as analysts assess the sustainability of these trends and market dynamics.
Bullish Takeaways- Bullish analysts are encouraged by Nasdaq's accelerating revenue growth, particularly across its solutions and financial technology segments. This signals continued business transformation.
- Analysts note a constructive macro environment and recovering capital markets. These factors are expected to drive further top-line and earnings growth into 2026.
- Multiple research notes highlight upgrades in outlook and price targets, attributing these moves to strong quarterly results and higher-quality, recurring revenue streams.
- Successful integrations of recent acquisitions and enterprise wins in fintech and regulatory technology are believed to improve revenue visibility and support further share re-rating.
- Some analysts express caution around the durability of recent growth, citing lower revenues in certain business lines such as Index. These may offset gains elsewhere.
- While the options segment saw notable improvement, waning market volatility could limit trading-related growth in the near term.
- Adjustments in price targets reflect a careful approach towards upcoming earnings, with expectations for steady results but few major surprises.
- Despite ongoing transformation, analysts will be closely watching for consistent delivery on medium-term growth guidance, especially as market conditions evolve.
What's in the News
- Nasdaq CEO Adena Friedman participated in a high-profile White House dinner with top Wall Street executives, highlighting the company's influence among major financial institutions (NY Post).
- Trading in Apollomics (APLM) shares was halted by Nasdaq pending additional information from the company. Trading will resume once Nasdaq's requests are satisfied (Periodicals).
- LSEG announced a strategic partnership with Nasdaq to distribute institutional-grade private markets intelligence, integrating Nasdaq's eVestment™ private markets datasets into LSEG's ecosystem (Key Developments).
- Nasdaq unveiled enhancements to its market surveillance platform, embedding advanced AI for more effective market abuse detection and enforcement capabilities (Key Developments).
Valuation Changes
- The Fair Value Estimate has risen slightly, increasing from $102.35 to $103.13 per share.
- The Discount Rate has fallen modestly, dropping from 8.64% to 8.54%.
- Projected Revenue Growth remains negative but has improved slightly, moving from -8.61% to -8.53%.
- The Net Profit Margin shows a minor decrease, edging down from 33.67% to 33.58%.
- The Future P/E Ratio has increased incrementally, rising from 34.95x to 35.05x.
Have other thoughts on Nasdaq?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.